Has Robert Zibelman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $21,482 in general payments to Robert Zibelman, MD across 362 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robert Zibelman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robert Zibelman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robert Zibelman, MD

Psychiatry · Huntingdon Valley, PANPI 1669402871

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $16,380 of the $21,482 with a category attached, or 76.2%. AbbVie accounts for 83.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $8,328 and has fallen 97.9% since, to $173 in 2025. Among psychiatry clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,482in general payments, 2019–2025

Across 362 payments — averaging $59.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$18K
Corium, LLC$576
Lundbeck LLC$546
Supernus Pharmaceuticals, Inc.$500
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$475
Takeda Pharmaceuticals U.S.A., Inc.$365
plus $1K from 8 others

What the payments were for

Speaking & faculty fees$16,38076%
Travel & lodging$5232%
Food & beverage$4,52021%
Education$590%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	183	$18,017
Corium, LLC	28	$576
Lundbeck LLC	70	$546
Supernus Pharmaceuticals, Inc.	1	$500
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	9	$475
Takeda Pharmaceuticals U.S.A., Inc.	25	$365
Otsuka America Pharmaceutical, Inc.	7	$326
Axsome Therapeutics, Inc.	8	$281
Neos Therapeutics, LP	20	$210
Shire North American Group Inc	5	$74
Johnson & Johnson	2	$51
Ironshore Pharmaceuticals Inc.	2	$28
Neurocrine Biosciences, Inc.	1	$18
Vertical Pharmaceuticals, LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VRAYLAR$15,986
CAPLYTA$358
Azstarys$261
REXULTI$242
Auvelity$231

How this compares

$21,482 in reported general payments places this provider in the 95th percentile of 1,838 psychiatry providers in Pennsylvania.

See all psychiatry providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$89,889

Medicare patients

Services billed

1,070

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Duloxetine Hcl	56	$2,403
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	82	$2,161
Bupropion XlBupropion Hcl	97	$2,129
Olanzapine	54	$1,770
Clonazepam	96	$1,677
Methylphenidate Hcl	32	$1,288
Alprazolam	147	$765
Escitalopram Oxalate	47	$675
Fluvoxamine Maleate	12	$630
Venlafaxine Hcl ErVenlafaxine Hcl	21	$580
Bupropion Hcl SrBupropion Hcl	26	$470
Lamotrigine	45	$462
Methylphenidate Hcl Er (Cd)Methylphenidate Hcl	12	$383
Gabapentin	26	$379
Mirtazapine	32	$344

Paid to pharmacies, not to this prescriber.

Other psychiatry in Huntingdon Valley

Rebecca RomaPittsburgh$3.3M
Robert NelsonWyomissing$2.2M
Matthew BergerMoosic$1.7M
Mark MattaNew Castle$847K
Mayer AyyashPittsburgh$714K
Daniel WeintraubPhiladelphia$647K
Sachin MehtaBlue Bell$646K
Jane JesseKingston$617K
Michael ThasePhiladelphia$396K
Michael KwiatBeaver$390K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →